Business Wire

Panasonic Develops High-Power Blue WBC Technology to Revolutionize DDL Applications on Microfabrication

29.1.2020 09:11:00 EET | Business Wire | Press release

Share

On January 29, 2020, Panasonic Corporation announced it has succeeded in demonstrating the world's highest brightness blue laser. This has been achieved by using the wavelength beam combining (WBC) technology [1] on a direct diode laser (DDL) to produce a high quality output beam [2]. With this technology, power scaling is enabled while maintaining the beam quality by simply increasing the number of laser sources. This demonstration opens the door to laser intensities that could be two orders of magnitude higher than conventional blue laser systems. This technology will contribute to the emerging microfabrication processes, whose demand is expected to grow in industrial applications, such as in the automotive industry.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200128005907/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Wavelength Beam Combining (WBC) technology (Graphic: Business Wire)

The automotive industry is moving towards “electrification” and “miniaturization” while requiring “high rigidity,” “design flexibility” and “productivity.” Against this background, the anticipation for the microfabrication lasers that can process various kinds of materials such as copper, gold and plastic is building up. Especially, blue laser with a high optical absorption efficiency has a high demand in the field of copper fabrication for the automotive motors and batteries. Highly-productive processing requires a laser beam source that has both high output power and high beam quality.

In order to attain such a beam source, Panasonic started collaboration with TeraDiode, Inc. (TDI), a Massachusetts, U.S.-based company, in 2013, and since has been developing WBC technology which can combine multiple and different wavelengths into one combined beam. In 2014, Panasonic released LAPRISS; the world’s first laser welding robot system equipped with an infrared DDL using WBC technology*1. In 2017, the company acquired TDI as a wholly owned subsidiary*2 and started developing on the output-power optimization on WBC as well as shortening the wavelength.

The output power optimization of the high-beam-quality blue laser (wavelength band = 400 – 450nm) was realized by combining more than 100 emitters from multiple diode bars [3] with WBC technology.

This WBC technology combines the beams from multiple emitters at different wavelengths that are incident on the diffraction grating at angles corresponding to each wavelength. The resonator is then formed in between the shared partially-transparent mirror and each edge face of the emitters. As a result, the output beam has achieved a output of 135 W with a high beam quality of BPP [4] 1.5mm・mrad.

Going forward, Panasonic will develop a processing system that is equipped with this laser beam source, as well as the process optimization in laser processing.

Panasonic will hold exhibits and lecture sessions on our technical achievement at PHOTONICS WEST 2020 in San Francisco from February 1 to 6, 2020.*3

A part of this research and development includes the data obtained from a project – “Development of advanced laser processing with intelligence based on high-brightness and high-efficiency laser technologies (TACMI project)” – commissioned by the New Energy and Industrial Technology Development Organization (NEDO) of Japan.

[Applications] Laser processing (welding, cutting, etc.)

[Patents] Total of 571 patents both domestic and international (including pending applications)

Notes:
*1: Panasonic Corporation Topics
April 15th, 2014: Panasonic has Released a Laser Welding Robot System "LAPRISS"-Equipped with the world's first high-power direct diode laser
https://news.panasonic.com/jp/topics/2014/38440.html (In Japanese)
*2: Panasonic Corporation News Release
January 6th, 2017: Panasonic Acquires All Shares of U.S.-Based Industrial Laser Start-up TeraDiode, Inc.
https://news.panasonic.com/global/press/data/2017/01/en170106-3/en170106-3.html
*3: PHOTONICS WEST 2020, San Francisco, 1-6 February 2020

Glossary
[1] Wavelength Beam Combining (WBC) technology: The technology that combines the beams with different wavelengths that are emitted from the multiple DDLs (direct diode lasers) on a diffraction grating.

[2] Beam quality: An index indicates how easy it is to combine the beam. Higher beam quality has smaller diameter and highly collimate feature.

[3] Diode bar: A laser bar that has multiple emittance stripes (emitters) in an array configuration on a single semiconductor chip.

[4] BPP (Beam Parameter Products): This is defined as the product of the radius r0 of the beam waist at the focusing position multiplied by the half-value half-width θ of the beam divergence angle; BPP = r0xθ. The unit is expressed in [mm・mrad]. The smaller BPP is, the higher the beam quality becomes.

About Panasonic
Panasonic Corporation is a worldwide leader in the development of diverse electronics technologies and solutions for customers in the consumer electronics, housing, automotive, and B2B businesses. The company, which celebrated its 100th anniversary in 2018, has expanded globally and now operates 582 subsidiaries and 87 associated companies worldwide, recording consolidated net sales of 8.003 trillion yen for the year ended March 31, 2019. Committed to pursuing new value through innovation across divisional lines, the company uses its technologies to create a better life and a better world for its customers. To learn more about Panasonic: https://www.panasonic.com/global.

Source: https://news.panasonic.com/global/press/data/2020/01/en200129-2/en200129-2.html

Related Links
Industrial Devices & Solutions - Panasonic
https://industrial.panasonic.com/ww

TeraDiode, Inc.
https://www.teradiode.com/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Manufacturing Innovation Division
Promotion & Engineering Planning Department
Panasonic Corporation
Email: midpress@ml.jp.panasonic.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye